Maxime Barakat

5PUBLICATIONS
14CO-AUTHORS
Molecular targetsDental therapeutics, pharmacology and toxicologyGene and molecular therapyInfectious diseasesRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 16, 2026
Canadian Treat-to-Target Practice Survey of Real-World Interventions and Strategies in Psoriasis (CAN TARGET PSORIASIS).

|Mar 18, 2025
Brodalumab for Plaque Psoriasis in the Canadian Real-World Setting: A Retrospective Cohort Analysis of up to 4 Years.

Veronique Gaudet, Irina Turchin, Charles W Lynde

|Jun 27, 2024
Clinico-Virological Outcomes and Mutational Profile of SARS-CoV-2 in Adults Treated with Ribavirin Aerosol for COVID-19 Pneumonia.

Giulia Morsica, Emanuela Messina, Sabrina Bagaglio

|Nov 03, 2022
Ribavirin aerosol in hospitalized adults with respiratory distress and COVID-19: An open-label trial.

Garyfallia Poulakou, Maxime Barakat, Robert J Israel

|Jun 09, 2022
A randomized, placebo-controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin.

Peter Couroux, Alexandre Brkovic, Jason L Vittitow

Pageof 1

Frequent Collaborators

2 joint publications

Vimal H Prajapati

1 joint publications

Giulia Morsica

1 joint publications

Riccardo Lolatto

1 joint publications

Robert J Israel